Organon (OGN) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BNP Paribas | Downgraded | Outperform → Neutral | $14.00 from $12.00 | Apr 29, 2026 |
| Piper Sandler | Upgraded | Underweight → Neutral | $14.00 from $5.00 | Apr 28, 2026 |
| Barclays | Maintained | Underweight | $8.00 from $7.50 | Feb 24, 2026 |
| Barclays | Initiated Coverage | Underweight | $7.50 | Dec 9, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $9.00 from $10.00 | Nov 11, 2025 |
| JP Morgan | Maintained | Underweight | $12.00 from $14.00 | Nov 11, 2025 |
| Piper Sandler | Maintained | Overweight | $18.00 from $24.00 | May 15, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $10.00 from $15.00 | May 5, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $15.00 from $16.00 | Apr 9, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $16.00 from $17.00 | Feb 14, 2025 |
| Barclays | Maintained | Overweight | $24.00 from $26.00 | Feb 14, 2025 |
| JP Morgan | Downgraded | Neutral → Underweight | $20.00 from $18.00 | Sep 6, 2024 |
| Goldman Sachs | Maintained | Neutral | $20.00 from $18.00 | May 6, 2024 |
| Goldman Sachs | Maintained | Neutral | $20.00 from $18.00 | May 3, 2024 |
| Piper Sandler | Maintained | Overweight | $24.00 from $22.00 | Apr 29, 2024 |
| Goldman Sachs | Maintained | Neutral | $18.00 from $16.00 | Feb 20, 2024 |
| Piper Sandler | Maintained | Overweight | $22.00 from $32.00 | Nov 22, 2023 |
| Goldman Sachs | Downgraded | Buy → Neutral | $16.00 from $33.00 | Nov 3, 2023 |
| Piper Sandler | Maintained | Overweight | $32.00 from $33.00 | Oct 25, 2023 |
| Morgan Stanley | Maintained | Equal-Weight | $22.00 from $27.00 | Oct 11, 2023 |
Frequently asked questions
Is OGN a buy, sell, or hold?
Analysts covering Organon currently average a Hold rating: 0 buy, 1 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on OGN?
On Apr 29, 2026, BNP Paribas downgraded Organon to Neutral with a price target of $14.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.